Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Learning points
- Features of AD inheritance
- How might an AD condition affect a family?
- Heritable thoracic aortic aneurysms & dissections
- Expected genotypes for children of an individual with an AD disorder
- AD inheritance – offspring genotype ratios for carrier parents
- AD disorders show different classes of mutation
- Osteogenesis imperfecta (1)
- Osteogenesis imperfecta (2)
- Collagen synthesis
- Type 1 OI severity is determined by the COL1A1/COL1A2 mutation
- Rasopathies
- Neurofibromatosis type 1
- Neurofibromatosis type 1 in childhood
- Rasopathies and the Ras/Raf/MEK/ERK signal transduction pathway
- Noonan syndrome
- Anticipation
- Myotonic dystrophy type 1 (MD1)
- Anticipation example: myotonic dystrophy
- Molecular mechanism of anticipation in myotonic dystrophy
- Huntington disease
- Huntington disease: normal & disease alleles
- Poly Q disease: linked to abnormal protein processing
- Polyglutamine repeat size correlates with age of onset
- Reduced penetrance
- Reduced Penetrance: example
- Reduced penetrance has implications for genetic counselling
- What is the likelihood of Elizabeth being a carrier?
- Risk of Elizabeth's baby developing retinoblastoma
- De novo mutations
- Frequency of de novo gene changes
- Complications of de novo mutations
- De novo mutations: parent of origin effect
- Selective advantage of de novo mutations in the testes
- Achondroplasia, thanatophoric dysplasia & skeletal dysplasias
- Mosaicism
- Differences between somatic & germline mosaicism
- Neurofibromatosis type 2
- AD Inheritance – homozygosity in AD skeletal dysplasias
- AD Inheritance – double heterozygosity in skeletal dysplasias
- Summary
Topics Covered
- Autosomal dominant disorders
- Genetics
- Inheritance
- Genetic disorders
- Osteogenesis imperfecta
- RASopathies
- Huntington disease
- Penetrance
- De novo mutations
Talk Citation
Holden, S. (2021, March 29). Autosomal dominant inheritance [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/HQBY2493.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Simon Holden has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Other Talks in the Series: Introduction to Human Genetics and Genomics
Transcript
Please wait while the transcript is being prepared...
0:00
I'm Dr. Simon Holden,
a consultant in clinical genetics in
the Department of Clinical Genetics at Addenbrooke's Hospital in Cambridge.
I'm also an associate lecturer at
the University of Cambridge and this presentation is on dominant inheritance.
0:16
This is a relatively common form of inheritance and we'll cover some of
the broader aspects as well as some of the details that students should be aware of.
At the end of this lecture,
students should understand autosomal dominant inheritance.
They should be familiar with this and how to recognise it from a family tree.
They should also be familiar with some of the more common autosomal dominant conditions.
Students should understand the importance of penetrance, and
variable expressivity and anticipation in relation
to these disorders, and have an understanding of
the importance of mosaicism and its relevance to genetic counselling.
They should be able to describe autosomal dominant inheritance
and the associated features to a patient.
0:58
This slide shows the features of autosomal dominant inheritance.
These are caused by a mutation (or pathogenic variant) in a single autosomal gene.
An individual will be at risk if they're heterozygous for the mutation.
The trait or disorder is transmitted from generation to
generation, that is to say, it shows vertical inheritance or transmission.
Males and females are usually equally affected.
An affected parent of either sex can transmit the disorder to both sons and daughters.
An affected parent transmits the condition, on average,
to half their sons and half their daughters i.e.,
there is a one-in-two or 50 percent offspring risk.
Importantly, dominant inheritance is distinguished
from X-linked inheritance by male-to-male transmission.